Patient views of therapeutic interchange of ACE inhibitors in Australian primary care: a qualitative study

Abstract

OBJECTIVES: In Australia, therapeutic interchange of angiotensin-converting enzyme (ACE) inhibitors could generate savings for patients and the Pharmaceutical Benefits Scheme (PBS). The PBS subsidises nine drugs in the ACE inhibitor class. These drugs are therapeutically equivalent, but the price varies between each drug. Patients are key players in successful therapeutic interchange programmes, but little is known about their views. This study aims to explore patient views of therapeutic interchange of ACE inhibitors in Australian primary care. DESIGN: Qualitative exploratory research study using semi-structured interviews, asking participants about therapeutic interchange and their attitud..